E-LIB Suche - Ergebnisse für: Nakao, Shinji

1

HLA Class I Allele Loss and Bone Marrow Transplantation Out..:

Zaimoku, Yoshitaka ; Katagiri, Takamasa ; Nakagawa, Noriharu...
Transplantation and Cellular Therapy. 30 (2024) 3 - p. 281.e1-281.e13 , 2024

Link: https://doi.org/10.1016/..

2

Primary prophylaxis with G-CSF for patients with non-round ..:

Hirose, Takeshi ; Ito, Mamoru ; Tsuchihashi, Kenji...
International Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1007/..

3

Effectiveness and safety of primary prophylaxis of granuloc..:

Uchino, Keita ; Tamura, Shingo ; Kimura, Shoji...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 545-550 , 2024

Link: https://doi.org/10.1007/..

4

Case report: Immune pressure on hematopoietic stem cells ca..:

Shingai, Naoki ; Mizumaki, Hiroki ; Najima, Yuho...
Frontiers in Immunology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

5

Long-term efficacy and safety of romiplostim in refractory ..:

Mitani, Kinuko ; Lee, Jong Wook ; Jang, Jun Ho...
Blood Advances. 8 (2024) 6 - p. 1415-1419 , 2024

Link: https://doi.org/10.1182/..

6

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Nozawa, Kazuki ; Ozaki, Yukinori ; Yoshinami, Tetsuhiro...
International Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1007/..

7

Therapeutic use of granulocyte colony-stimulating factor (G..:

Tsuchihashi, Kenji ; Ito, Mamoru ; Okumura, Yuta...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 700-705 , 2024

Link: https://doi.org/10.1007/..

8

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Maeda, Tomoya ; Najima, Yuho ; Kamiyama, Yutaro...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 535-544 , 2024

Link: https://doi.org/10.1007/..

9

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Ichihara, Eiki ; Ochi, Nobuaki ; Makimoto, Go...
International Journal of Clinical Oncology. 29 (2024) 4 - p. 355-362 , 2024

Link: https://doi.org/10.1007/..

10

Optimal timing of prophylactic pegylated G-CSF after chemot..:

Ozaki, Yukinori ; Yokoe, Takamichi ; Yoshinami, Tetsuhiro...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 551-558 , 2024

Link: https://doi.org/10.1007/..

11

Effectiveness and safety of primary prophylaxis of G-CSF du..:

Kimura, Shoji ; Shigeta, Keisuke ; Tamura, Shingo...
International Journal of Clinical Oncology. 29 (2024) 5 - p. 559-563 , 2024

Link: https://doi.org/10.1007/..

12

Effectiveness and safety of primary prophylaxis with G-CSF ..:

Hirose, Takeshi ; Ito, Mamoru ; Tsuchihashi, Kenji...
International Journal of Clinical Oncology. , 2024

Link: https://doi.org/10.1007/..

13

Clinical impact and characteristics of erythroid dysplasia ..:

Maeda, Tomoya ; Matsuda, Akira ; Kanda, Junya...
British Journal of Haematology. 204 (2024) 5 - p. 2086-2096 , 2024

Link: https://doi.org/10.1111/..

14

Effectiveness of G-CSF in chemotherapy for digestive system..:

Ito, Mamoru ; Okumura, Yuta ; Nio, Kenta...
International Journal of Clinical Oncology. 29 (2024) 6 - p. 689-699 , 2024

Link: https://doi.org/10.1007/..

15

Effectiveness and safety of granulocyte colony-stimulating ..:

Najima, Yuho ; Maeda, Tomoya ; Kamiyama, Yutaro...
International Journal of Clinical Oncology. 29 (2024) 7 - p. 899-910 , 2024

Link: https://doi.org/10.1007/..